Skip to main content

Table 1 Comparison of the number of significant pairs.

From: Integrated analysis of microRNA-target interactions with clinical outcomes for cancers

 

Num of Significant Pairs (p-value < 0.01)

HH:LL

HL:LH

HH:HL

HH:LH

LL:LH

LL:HL

Ovarian

Cancer

Validation Pair

257

261

113

200

143

248

 

Total Pair

22,685

22,575

9,408

18,739

10,299

21,332

GBM

Validation Pair

234

250

229

171

161

229

 

Total Pair

47,706

51,217

22,180

36,023

22,835

42,735

  1. Comparison of the number of significant pairs (p-value <0.01) in total and validation for six pairwise survival test sets.